OGI
Organigram Global, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$0.97
+4.90%Forward multiples
Based on analyst estimates
- P/E forward
- 30.10x
- P/E 2026E
- 2.33x
- P/E 2027E
- 29.72x
- P/E 2028E
- 15.79x
- P/S forward
- 0.41x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.14x
- PEG TTM
- —
- Price / book
- 0.35x
- Price / sales
- 0.63x
- Price / cash flow
- -6.83x
Enterprise value
- Enterprise value
- $196.5M
- EV / sales
- 0.89x
- EV / EBITDA
- 14.95x
- EV / EBIT
- -41.12x
- Market cap
- $139.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026